2-Chlorodeoxyadenosine: a new nucleoside agent effective in the treatment of lymphoid malignancies.
about
A phase I and pharmacokinetics study of 2-chlorodeoxyadenosine in patients with solid tumors.Pentostatin and purine analogs for indolent lymphoid malignancies.Alemtuzumab in the treatment of fludarabine refractory B-cell chronic lymphocytic leukemia (CLL).New insights into the synergism of nucleoside analogs with radiotherapyClinical pharmacology and clinical trials of ribonucleotide reductase inhibitors: is it a viable cancer therapy?
P2860
2-Chlorodeoxyadenosine: a new nucleoside agent effective in the treatment of lymphoid malignancies.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
2-Chlorodeoxyadenosine: a new ...... ment of lymphoid malignancies.
@en
type
label
2-Chlorodeoxyadenosine: a new ...... ment of lymphoid malignancies.
@en
prefLabel
2-Chlorodeoxyadenosine: a new ...... ment of lymphoid malignancies.
@en
P2860
P1433
P1476
2-Chlorodeoxyadenosine: a new ...... ment of lymphoid malignancies.
@en
P2860
P356
10.3109/10428199309149111
P478
P577
1993-01-01T00:00:00Z